[The immunostimulating action of lactobacteria on the cytotoxicity of natural killer cells and interferon production]. 1994

I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev

UI MeSH Term Description Entries
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007778 Lactobacillus A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment PENTOSES. Most members were previously assigned to the Lactobacillus delbrueckii group. Pathogenicity from this genus is rare.
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1998, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1990, International journal of immunopharmacology,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
November 1981, Journal of immunology (Baltimore, Md. : 1950),
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1980, Duodecim; laaketieteellinen aikakauskirja,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1984, Critical reviews in immunology,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1980, Annals of the New York Academy of Sciences,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
February 2007, Blood,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
March 1981, The Journal of pediatrics,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
January 1981, Texas reports on biology and medicine,
I G Tsoĭ, and A S Saparov, and I K Timofeeva, and A B Dzhumagulova, and M G Bulegenova, and B D Seksenbaev
February 1986, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!